Ritwik Ghosh
- Clinical Psychology top 1%
- Neurology top 1%
- Long-Term Effects of COVID-19 18
- Neurological disorders and treatments 15
- Peripheral Neuropathies and Disorders 9
- Autoimmune Neurological Disorders and Treatments 9
- Applied Psychology top 5%
- Modeling and Simulation top 2%
- Infectious Diseases top 5%
- Infectious Encephalopathies and Encephalitis 16
-
- Neurological and metabolic disorders 22
-
- Neurological Complications and Syndromes 17
-
- Moyamoya disease diagnosis and treatment 11
- Co-authors
- Souvik DubeyMahua Jana DubeySubhankar ChatterjeeSubham ChatterjeePayel BiswasDurjoy LahiriCarl J. LavieJulián Benito‐León
- Journals
- Diabetes & Metabolic Syndrome Clinical Research & Reviews (8 papers)Cancer Research (6 papers)Journal of Neuroimmunology (4 papers)
- Partner nations
- IndiaSpainUnited States
In The Last Decade
Ritwik Ghosh
116 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Clinical Psychology 1.3k
- Neurology 890
- Applied Psychology 163
- Modeling and Simulation 135
- Infectious Diseases 419
Countries citing papers authored by Ritwik Ghosh
This map shows the geographic impact of Ritwik Ghosh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ritwik Ghosh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ritwik Ghosh more than expected).
Fields of papers citing papers by Ritwik Ghosh
This network shows the impact of papers produced by Ritwik Ghosh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ritwik Ghosh. The network helps show where Ritwik Ghosh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ritwik Ghosh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 1 | |
| 9 | 2022 | 7 | |
| 10 | 2021 | 0 | |
| 11 | 2021 | 26 | |
| 12 | 2021 | 0 | |
| 13 | 2021 | 15 | |
| 14 | 2021 | 0 | |
| 15 | 2021 | 36 | |
| 16 | 2021 | 9 | |
| 17 | ADVANCES IN THE UNDERSTANDING OF PATHOPHYSIOLOGY OF TYPE 2 DIABETES MELLITUS | 2020 | 1 |
| 18 | Psychosocial impact of COVID-19breakdown → | 2020 | 1264 |
| 19 | 2012 | 101 | |
| 20 | 2011 | 171 |
About Ritwik Ghosh
Ritwik Ghosh is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism, Infectious Diseases, Rheumatology and Psychiatry and Mental health, having authored 141 papers that have together received 3.4k indexed citations. Recurring topics across this work include Neurological and metabolic disorders (22 papers), Long-Term Effects of COVID-19 (18 papers), Neurological Complications and Syndromes (17 papers), Infectious Encephalopathies and Encephalitis (16 papers), Neurological disorders and treatments (15 papers), Moyamoya disease diagnosis and treatment (11 papers), Peripheral Neuropathies and Disorders (9 papers) and Autoimmune Neurological Disorders and Treatments (9 papers). The work is most often cited by research in Clinical Psychology (1.3k citations), Neurology (890 citations), Applied Psychology (163 citations), Modeling and Simulation (135 citations) and Infectious Diseases (419 citations). Ritwik Ghosh has collaborated with scholars based in India, Spain and United States. Frequent co-authors include Souvik Dubey, Mahua Jana Dubey, Subhankar Chatterjee, Subham Chatterjee, Payel Biswas, Durjoy Lahiri, Carl J. Lavie, Julián Benito‐León, Biman Kanti Ray and Dipayan Roy. Their work appears in journals such as Diabetes & Metabolic Syndrome Clinical Research & Reviews, Cancer Research, Journal of Neuroimmunology, Toxicon and Journal of Stroke and Cerebrovascular Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.